PS-08-016 Can intracavernosal botulinum toxin injection salvage vascular erectile dysfunction patients not responding to oral and intracavernous therapy? A pilot study

2016 ◽  
Vol 13 (5) ◽  
pp. S116 ◽  
Author(s):  
H. Ghanem ◽  
I. Soliman ◽  
M. AbdulHamid ◽  
R. Shamloul
2021 ◽  
Vol 25 (3) ◽  
Author(s):  
Zuzanna Olszewska ◽  
Elżbieta Mirek ◽  
Kinga Opoka-Kubica ◽  
Szymon Pasiut Szymon Pasiut ◽  
Magdalena Filip

Introduction: Stroke is a serious health problem in the modern population. Spasticity is one of the consequences of stroke and affects about 30% of people. Increased muscle tone affects postural control disorders. Due to the specificity of spasticity, therapy in post-stroke patients is a challenge for neurological physiotherapy. Therefore, it requires the development of appropriate management standards . Study aim: The aim of the study was to evaluate the effectiveness of 3 combination therapy cycles based on botulinum toxin injection and physiotherapy for muscle tone, muscle strength and postural stability in post-stroke patients qualified for the spasticity treatment programme of the lower and upper limbs. Material and methods: The pilot study involved 12 patients (6 from the lower limb and 6 from the upper limb programme). The 1-year combination therapy programmes included 3 botulinum toxin injections and 3 weeks of physiotherapy after each injection. Clinical evaluation was conducted before and after the 1-year observation cycle. The results were evaluated using: MAS (Modified Ashworth Scale), MRC (Medical Research Council Scale) and posture stability test on a balance platform (BiodexSD). Results: A decrease was observed in muscle tone of the lower and upper limbs, as well as an increase in muscular strength of the upper limb. However, there were no noted statistical significance of the studied parameters. Conclusions: Physiotherapy in combination with the botulinum toxin is an important element of improvement in post-stroke patients. However, further research is needed to explicitly confirm its effectiveness.


Author(s):  
Yi-Chiao Cheng ◽  
Jacqueline Yu-Min Beh ◽  
Po-Hsien Wu ◽  
Nien-Ying Tsai ◽  
Shu-Wen Jao

Author(s):  
Mostafa Soltan Sanjari ◽  
Khalil Ghasemi Falavarjani ◽  
Mohsen Bahmani Kashkouli ◽  
Gholam Hosseyn Aghai ◽  
Marzieh Nojomi ◽  
...  

2007 ◽  
Vol 27 (8) ◽  
pp. 882-885 ◽  
Author(s):  
Christopher John Newman ◽  
Ann Kennedy ◽  
Michael Walsh ◽  
Timothy O'Brien ◽  
Bryan Lynch ◽  
...  

2019 ◽  
Vol 90 (3) ◽  
pp. e40.1-e40
Author(s):  
R Mozdiak ◽  
R Lally ◽  
F Osei-Poku ◽  
J Alty

ObjectivesCervical dystonia (CD) is known to be associated with depression and low quality of life (QoL) but we know little about these measures in non-CD patients attending botulinum toxin clinics. The objective was to evaluate the prevalence of depression and low QoL in both CD and nonCD patients.DesignCross-sectional pilot study.SubjectsConsecutive patients attending teaching hospital botulinum toxin clinic.MethodsPatients completed the Beck’s Depression Inventory (BDI) questionnaire and a Recovering Quality of Life (ReQoL) scale. BDI and ReQoL scores of ≥17 and≤24 indicated depression and impaired QoL respectively.Results48 patients (30 female; age 45–75 years) were evaluated; 33:15 CD:non-CD. The non-CD group comprised hemifacial spasm, upper limb dystonia/tremor, blepharospasm and Meige syndrome. 23% (11/48) of all patients had depression: 27% (9/33) of CD and 13% (2/15) of non-CD. Depression rates were more frequent amongst females and males (27%; 17%) (p=0.43). 34% of all patients had low QoL – 36% (12/33) and 27% (4/15) in the CD and non-CD groups respectively (p=0.51). Low QoL scores were more frequent in females (40%) than males (22%) but this difference was not significant (p=0.21).ConclusionsDepression and low quality of life were common in all patients in this pilot study. This suggests that screening of all patients attending botulinum toxin clinics, regardless of their diagnosis, may be clinically important. A larger study is required to validate these findings.


Sign in / Sign up

Export Citation Format

Share Document